Eppendorf SE returns to a structure with only one CEO The previous Co-CEOs, Eva van Pelt and Dr. Peter Fruhstorfer, leave the company by mutual agreement The position of the CEO will be filled Until further notice Dr. Wilhelm Plüster will take on the role as spokesperson for the Management Board The Management Board is […]
VANCOUVER, British Columbia — STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report today. The report, entitled Toward Sustainable Science, provides a comprehensive look at STEMCELL’s environmental, social, and governance performance over the company’s 2023 Fiscal Year (July 1, 2022 through June 30, 2023). “As a company of Scientists Helping Scientists, we know […]
Corriveau brings 25 years of commercial and operational leadership experience in life sciences, biopharma, and diagnostics from Ultivue, AstraZeneca, Roche and NanoString DURHAM, N.C. — Codetta Bio, the life sciences company developing advanced multi-omic biomarker measurement tools, announced today that Jacques Corriveau has been appointed as its new Chief Executive Officer. In this role, Corriveau […]
SOUTH SAN FRANCISCO, Calif. — NanoTemper Technologies, creator of high-quality, easy-to-learn biophysical tools for drug discovery, launches a new way for biologics researchers to screen humanized antibody therapeutics with the release of their Human Fc Labeling Kit. Optimized for use with Spectral Shift technology, an in-solution affinity screening method, scientists looking for innovative ways to […]
Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to […]
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial cross-selling opportunities and complementary offerings Generates estimated $80 million of annual cost synergies by 2026 and enhanced combined path to profitability1 […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE […]
Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024. Over the Q4 2023 period, Gerry will transition into his new role working with Jonathan Flint, Executive Chairman and the Leadership Team at Refeyn. Gerry brings extensive […]
Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: “We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
